CDSCO – Page 12 – Express Pharma

Bajaj Healthcare applies to Indian patent office for compulsory licence for Baricitinib

Mankind Pharma partners with BDR Pharma to distribute Baricitinib in India

Zydus Cadila gets CDSCO nod for clinical trials of antibodies cocktail to treat COVID-19: Sources

Cipla to market Roche’s antibody cocktail pan-India, first batch currently available

Lilly signs voluntary licensing agreement with Natco for baricitinib

SEC recommends phase II/III clinical trials of Covaxin on 2-18 year-olds

Cipla signs licensing deal with Lilly to manufacture and commercialise baricitinib in India

DCGI nod for anti-COVID 19 drug developed by DRDO

Roche’s antibody cocktail for COVID-19 may face affordability issues in India: GlobalData

Roche gets EUA in India for antibody cocktail (Casirivimab and Imdevimab) to treat COVID-19